Hepatocyte xenografts for treatment of acute liver failure
肝细胞异种移植治疗急性肝衰竭
基本信息
- 批准号:9128195
- 负责人:
- 金额:$ 103.4万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-03-15 至 2021-02-28
- 项目状态:已结题
- 来源:
- 关键词:AcuteAcute Liver FailureAllograftingAmmoniaAnimalsAntigensArtificial LiverBiologicalBiological AssayCellsClinicalClinical MedicineComplexDevicesEmergency SituationEvaluationExperimental DesignsFailureFamily suidaeFunctional disorderHepatocyteHepatocyte transplantationHumanImageImmuneImmune responseImmunityImmunosuppressionImmunosuppressive AgentsInbreedingInfusion proceduresInjuryIntracranial HypertensionLifeLiverLiver FailureMetabolicMethodsModelingMonkeysNatural regenerationOrgan TransplantationPatientsPharmaceutical PreparationsPortal vein structurePre-Clinical ModelReportingResearchRestSourceTestingTherapeutic immunosuppressionTimeTransplant RecipientsTransplantationXenograft procedurebody systemgraft failuregraft functionimmunosuppressedimprovedimproved outcomeinnovationinterestliver allograftliver functionliver injuryliver transplantationnonhuman primatenovel strategiespre-clinicalpublic health relevancerepairedresearch studytheories
项目摘要
DESCRIPTION (provided by applicant): The proposed research tests whether swine hepatocyte xenografts can improve survival in acute or fulminant liver failure. Acute liver failure
poses an extraordinary clinical challenge. This challenge reflects in part the complex, life-threatening pathophysiology of the condition. However, it also reflects the view that approximately one third, and possibly more of those most severely afflicted with acute liver failure, could recover liver function if effective artificial or biological support were available.
Instead, these patients typically undergo emergency orthotopic liver transplantation or they die. Anecdotal reports in humans and experiments in animals suggest that transplantation of isolated hepatocytes into the damaged liver, by infusion in the portal vein, might obviate the need for organ transplantation in patients with liver failure. Since human livers are in short supply, interest has focused on use of hepatocytes from animals, especially swine, the hepatocytes of which are sometimes incorporated in artificial liver support devices. Our research employs the first reproducible model of acute liver failure in non-human primates and new approaches to imaging grafted cells and assaying immune responses that ensue. With these innovations, the proposed research will reveal, in a pre-clinical setting, 1) the extent to which swine hepatocyte xenografts can support life and reverse the key pathophysiologic manifestations of acute liver failure, 2) whether immune or non-immune barriers limit the impact of the grafts or cause the grafts to fail, and 3) the conditions in which failure can be reversed b increased immunosuppression and/or provision of another hepatocyte xenograft. Besides potentially providing proof of principle, the research may advance broader application of the model of acute liver failure, approaches to tracing the fate of grafted cells and the immune response they provoke.
描述(由申请方提供):拟定的研究测试了猪肝细胞异种移植物是否可以改善急性或暴发性肝衰竭的存活率。急性肝衰竭
提出了一个非凡的临床挑战。这一挑战部分反映了该疾病复杂的、危及生命的病理生理学。然而,它也反映了这样一种观点,即如果有有效的人工或生物支持,大约三分之一,可能更多的最严重的急性肝功能衰竭患者可以恢复肝功能。
相反,这些患者通常接受紧急原位肝移植或死亡。在人类和动物实验中的轶事报告表明,通过门静脉输注将分离的肝细胞移植到受损的肝脏中,可能会减少肝功能衰竭患者对器官移植的需求。由于人类肝脏供应短缺,人们的兴趣集中在使用来自动物,特别是猪的肝细胞,其肝细胞有时被并入人工肝支持装置中。我们的研究采用了第一个可重复的非人灵长类动物急性肝功能衰竭模型和新的方法来成像移植细胞和测定随之而来的免疫反应。通过这些创新,拟议的研究将在临床前环境中揭示:1)猪肝细胞异种移植物可以支持生命并逆转急性肝衰竭的关键病理生理学表现的程度,2)免疫或非免疫屏障是否限制了移植物的影响或导致移植物失败,和3)通过增加免疫抑制和/或提供另一种肝细胞异种移植物可以逆转衰竭的条件B。除了可能提供原理证明外,这项研究还可能推动急性肝衰竭模型的更广泛应用,追踪移植细胞命运及其引发的免疫反应的方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ira J. Fox其他文献
Clonal deletion: a mechanism of tolerance in mixed bone marrow chimeras.
克隆缺失:混合骨髓嵌合体的耐受机制。
- DOI:
- 发表时间:
1990 - 期刊:
- 影响因子:2.2
- 作者:
Jack C. Yu;Marianne Webster;Ira J. Fox - 通讯作者:
Ira J. Fox
A new technique for combined liver/small intestinal transplantation.
肝/小肠联合移植新技术。
- DOI:
10.1097/00007890-200112150-00025 - 发表时间:
2001 - 期刊:
- 影响因子:6.2
- 作者:
D. Sudan;Kishore Iyer;Arnaud DeRoover;S. Chinnakotla;Ira J. Fox;B. Shaw;A. Langnas - 通讯作者:
A. Langnas
Human hepatocyte transplantation: gene therapy and more?
人肝细胞移植:基因疗法等等?
- DOI:
- 发表时间:
1998 - 期刊:
- 影响因子:8
- 作者:
J. Chowdhury;N. Chowdhury;Stephen C. Strom;Stuart S. Kaufman;Simon Horslen;Ira J. Fox - 通讯作者:
Ira J. Fox
Ira J. Fox的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ira J. Fox', 18)}}的其他基金
Hepatocyte Transplantation for Liver Based Metabolic Disease
肝细胞移植治疗肝脏代谢疾病
- 批准号:
9762098 - 财政年份:2018
- 资助金额:
$ 103.4万 - 项目类别:
Hepatocyte xenografts for treatment of acute liver failure
肝细胞异种移植治疗急性肝衰竭
- 批准号:
9236158 - 财政年份:2016
- 资助金额:
$ 103.4万 - 项目类别:
Regulation of HNF4 in Hepatic Failure in Cirrhosis
HNF4 在肝硬化肝衰竭中的调控
- 批准号:
9084549 - 财政年份:2013
- 资助金额:
$ 103.4万 - 项目类别:
Regulation of HNF4 in Hepatic Failure in Cirrhosis
HNF4 在肝硬化肝衰竭中的调控
- 批准号:
8892178 - 财政年份:2013
- 资助金额:
$ 103.4万 - 项目类别:
Regulation of HNF4 in Hepatic Failure in Cirrhosis
HNF4 在肝硬化肝衰竭中的调控
- 批准号:
8698412 - 财政年份:2013
- 资助金额:
$ 103.4万 - 项目类别:
Regulation of HNF4 in Hepatic Failure in Cirrhosis
HNF4 在肝硬化肝衰竭中的调控
- 批准号:
8560395 - 财政年份:2013
- 资助金额:
$ 103.4万 - 项目类别:
Models of AT Deficiency Using Human Hepatocytes
使用人肝细胞的 AT 缺陷模型
- 批准号:
10630350 - 财政年份:2012
- 资助金额:
$ 103.4万 - 项目类别:
Models of AT Deficiency Using Human Hepatocytes
使用人肝细胞的 AT 缺陷模型
- 批准号:
10197889 - 财政年份:2012
- 资助金额:
$ 103.4万 - 项目类别:
Models of AT Deficiency Using Human Hepatocytes
使用人肝细胞的 AT 缺陷模型
- 批准号:
10441251 - 财政年份:2012
- 资助金额:
$ 103.4万 - 项目类别:
Xenogeneic Hepatocyte Transplantation for Cirrhosis
异种肝细胞移植治疗肝硬化
- 批准号:
6686109 - 财政年份:2003
- 资助金额:
$ 103.4万 - 项目类别:
相似海外基金
Senescent hepatocytes mediate reprogramming of immune cells in acute liver failure
衰老肝细胞介导急性肝衰竭中免疫细胞的重编程
- 批准号:
10679938 - 财政年份:2023
- 资助金额:
$ 103.4万 - 项目类别:
Hepatocytes Encapsulated with mesenchymal stromal cells in alginate microbeads for the treatment of acute Liver failure in Paediatric patients (HELP)
将间充质基质细胞封装在藻酸盐微珠中的肝细胞用于治疗儿科患者的急性肝衰竭(HELP)
- 批准号:
MR/V038583/1 - 财政年份:2022
- 资助金额:
$ 103.4万 - 项目类别:
Research Grant
Pediatric Acute Liver Failure Immune Response Network (PALF IRN): Treatment for Immune Mediated Pathophysiology (TRIUMPH)
小儿急性肝衰竭免疫反应网络 (PALF IRN):免疫介导的病理生理学治疗 (TRIUMPH)
- 批准号:
10421290 - 财政年份:2021
- 资助金额:
$ 103.4万 - 项目类别:
Development of the innovative treatment using self iPS cell for acute liver failure
开发利用自身 iPS 细胞治疗急性肝衰竭的创新疗法
- 批准号:
21K08685 - 财政年份:2021
- 资助金额:
$ 103.4万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Pediatric Acute Liver Failure Immune Response Network (PALF IRN): Treatment for Immune Mediated Pathophysiology (TRIUMPH)
小儿急性肝衰竭免疫反应网络 (PALF IRN):免疫介导的病理生理学治疗 (TRIUMPH)
- 批准号:
10180251 - 财政年份:2021
- 资助金额:
$ 103.4万 - 项目类别:
Therapeutic effect of plasmacytoid dendritic cells transplantation for acute liver failure
浆细胞样树突状细胞移植治疗急性肝衰竭的疗效
- 批准号:
20K21607 - 财政年份:2020
- 资助金额:
$ 103.4万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Macrophage Therapy for Acute Liver Failure
巨噬细胞治疗急性肝衰竭
- 批准号:
MR/T044802/1 - 财政年份:2020
- 资助金额:
$ 103.4万 - 项目类别:
Research Grant
Investigation of an optimal environment for the proliferation of mature hepatocytes toward the rescue of acute liver failure patients
研究成熟肝细胞增殖的最佳环境以挽救急性肝衰竭患者
- 批准号:
19K08475 - 财政年份:2019
- 资助金额:
$ 103.4万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Pediatric Acute Liver Failure (PALF) TReatment for ImmUne Mediated PathopHysiology (TRIUMPH)
小儿急性肝衰竭 (PALF) 免疫介导病理生理学治疗 (TRIUMPH)
- 批准号:
9789253 - 财政年份:2018
- 资助金额:
$ 103.4万 - 项目类别:
Cryopreservation of hiPS-derivd hepatic progenitor cells and application to acute liver failure treatment
hiPS源性肝祖细胞的冷冻保存及其在急性肝衰竭治疗中的应用
- 批准号:
18K08662 - 财政年份:2018
- 资助金额:
$ 103.4万 - 项目类别:
Grant-in-Aid for Scientific Research (C)